These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 15789127)

  • 1. Development and evaluation of the Parkinson Psychosis Questionnaire A screening-instrument for the early diagnosis of drug-induced psychosis in Parkinson's disease.
    Brandstaedter D; Spieker S; Ulm G; Siebert U; Eichhorn TE; Krieg JC; Oertel WH; Eggert K
    J Neurol; 2005 Sep; 252(9):1060-6. PubMed ID: 15789127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parkinson Psychosis Rating Scale: a practical instrument for grading psychosis in Parkinson's disease.
    Friedberg G; Zoldan J; Weizman A; Melamed E
    Clin Neuropharmacol; 1998; 21(5):280-4. PubMed ID: 9789707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subclinical elevation of plasma C-reactive protein and illusions/hallucinations in subjects with Parkinson's disease: case-control study.
    Sawada H; Oeda T; Umemura A; Tomita S; Hayashi R; Kohsaka M; Yamamoto K; Sudoh S; Sugiyama H
    PLoS One; 2014; 9(1):e85886. PubMed ID: 24497930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychosis assessment in early-stage Parkinson's disease: comparing Parkinson's psychosis questionnaire with the brief psychiatric rating scale in a portuguese sample.
    Cargaleiro I; Serra M; Alves da Silva J; Neto B; Gonçalves-Pereira M; Bugalho P
    Parkinsons Dis; 2012; 2012():469126. PubMed ID: 22690350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quetiapine improves psychotic symptoms and cognition in Parkinson's disease.
    Juncos JL; Roberts VJ; Evatt ML; Jewart RD; Wood CD; Potter LS; Jou HC; Yeung PP
    Mov Disord; 2004 Jan; 19(1):29-35. PubMed ID: 14743357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychosis in Parkinson's disease.
    Poewe W
    Mov Disord; 2003 Sep; 18 Suppl 6():S80-7. PubMed ID: 14502660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clozapine prevents recurrence of psychosis in Parkinson's disease.
    Factor SA; Brown D
    Mov Disord; 1992; 7(2):125-31. PubMed ID: 1350059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Parkinson's disease and psychoses].
    Bizzarri JV; Giupponi G; Maniscalco I; Schroffenegger P; Conca A; Kapfhammer HP
    Neuropsychiatr; 2015; 29(1):1-13. PubMed ID: 25586068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clozapine in the treatment of adverse psychiatric manifestations of long-term therapy with levodopa].
    Svetel MV; Sternić NM; Filipović SR; Vojvodić NM; Kostić VS
    Srp Arh Celok Lek; 1997; 125(7-8):203-6. PubMed ID: 9304232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Levodopa-induced psychosis in patients with idiopathic Parkinson disease].
    García-Escrig M; Bermejo Pareja F; Fernández Ponsatí JT
    Med Clin (Barc); 1999 Feb; 112(7):245-50. PubMed ID: 10220750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of clozapine to treat levodopa-induced psychosis in Parkinson's disease: retrospective review.
    Widman LP; Burke WJ; Pfeiffer RF; McArthur-Campbell D
    J Geriatr Psychiatry Neurol; 1997 Apr; 10(2):63-6. PubMed ID: 9188021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parkinsonism in multiple system atrophy: natural history, severity (UPDRS-III), and disability assessment compared with Parkinson's disease.
    Tison F; Yekhlef F; Chrysostome V; Balestre E; Quinn NP; Poewe W; Wenning GK
    Mov Disord; 2002 Jul; 17(4):701-9. PubMed ID: 12210859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hallucinations in Parkinson's disease].
    Moser A; Hagenah J; Kömpf D
    Nervenarzt; 2003 Apr; 74(4):376-85, quiz 385-6. PubMed ID: 12707709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-induced psychosis in Parkinson disease: phenomenology and correlations among psychosis rating instruments.
    Chou KL; Messing S; Oakes D; Feldman PD; Breier A; Friedman JH
    Clin Neuropharmacol; 2005; 28(5):215-9. PubMed ID: 16239760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose clozapine for the treatment of drug-induced psychosis in Parkinson's disease.
    Parkinson Study Group
    N Engl J Med; 1999 Mar; 340(10):757-63. PubMed ID: 10072410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for dementia, depression and psychosis in long-standing Parkinson's disease.
    Giladi N; Treves TA; Paleacu D; Shabtai H; Orlov Y; Kandinov B; Simon ES; Korczyn AD
    J Neural Transm (Vienna); 2000; 107(1):59-71. PubMed ID: 10809404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melperone in the treatment of iatrogenic psychosis in Parkinson's disease.
    Barbato L; Monge A; Stocchi F; Nordera G
    Funct Neurol; 1996; 11(4):201-7. PubMed ID: 8934152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mianserin treatment of patients with psychosis induced by antiparkinsonian drugs.
    Ikeguchi K; Kuroda A
    Eur Arch Psychiatry Clin Neurosci; 1995; 244(6):320-4. PubMed ID: 7772616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Value of clozapine in treatment of psychotic disorder in Parkinson disease].
    Abbar M; Courtet P; Castelnau D
    Encephale; 1996; 22(1):53-63. PubMed ID: 8681876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Psychoses in patients with Parkinson's disease; their frequency, phenomenology, and clinical correlates].
    Kashihara K; Ohno M; Katsu Y
    Rinsho Shinkeigaku; 2005 Jan; 45(1):1-5. PubMed ID: 15714992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.